The present disclosure relates to a wearable device that includes a housing, battery terminal connector, conductive traces, and an insulator for recording signals. The device may include a housing enclosing a circuit board and a battery. The device may include two conductive traces electrically connected to terminals of the battery and an insulator separating the conductive traces. The battery terminal connector can present both the conductive traces to the outer surface for coupling to a circuit board. The device can assess the physiological signals to infer a likelihood of arrhythmia of a user.

The present invention relates to a body monitoring system comprising a patch, the patch comprising a main body, the main body comprising a second face suitable for facing the skin of a user, the patch comprising an adhesive layer at least partially covering the second face, and a peelable cover covering the adhesive layer, the peelable cover comprising at least two separate portions, the portions being adjacent to each other, the main body and the adhesive layer comprise a central portion forming an opening suitable for receiving the capsule, the opening having a maximum diameter greater than 2 mm, preferably greater than 5 mm.

A body fluid analyte detection device, includes: a transmitter, provided with at least one first fastener part; a bottom case, provided with at least one second fastener part corresponding to the first fastener part, and the bottom case including at least one fixed portion and at least one force-receiving portion. When separating the bottom case and the transmitter, the fixed portion is fixed and a force is applied to the force-receiving portion in one direction, separating the bottom case and the transmitter. The body fluid analyte detection device further includes a sensor connected with the transmitter to transmit the parameter signal; and a battery assembled in the bottom case or in the transmitter. The part holding the battery is the battery portion. A force is applied to the force-receiving portion in only one direction to make the bottom case fail and thereby separating the transmitter and the bottom case, simplifying user action and enhancing user experience.

A sensor assembly includes a carrier having a base wall and a pair of side walls extending from the base wall, and a sensor mounted on the base wall between the side walls. Each of the side walls has a side step between a first side section and a second side section extending from the first side section along a longitudinal direction of the carrier. A sensor die of the sensor is spaced in a width direction perpendicular to the longitudinal direction by a first lateral gap distance from the first side section and by a second lateral gap distance from the second side section. The second lateral gap distance is greater than the first lateral gap distance.

The present disclosure relates to a wearable device with a bridge portion and systems/methods relating to the device. Preferred embodiments may include two flexible wings and a bridge connecting the two wings. In some embodiments, the upper surface of the bridge can be non-adhesive and uncoupled to the flexible wing such that the flexible wing can be decoupled from the bridge when the adhesive is adhered to the surface of a user. The bridge can be narrower in some portions, and extend around the housing of the monitor. The bridge can extend beneath the housing and bisect the two flexible wings.

The present invention provides a removable optical imaging device cap for use with a near infrared (NIR) light optical imaging device for detecting intracranial hematoma.

Persons with sleep disordered breathing (SDB) may, or may not, recognize that they have symptoms of SDB, and/or that they may be at-risk of, or suffering certain health problems associated with SDB, including death. The disclosed Energy Conversion Monitor (ECM) sensor, when embodied, for example, in a wearable upper-armband format, has been demonstrated to be more sensitive and responsive than pulse oximetry monitoring of blood oxygen saturation as an indication of hypoxic stress induced by SDB, and is compatible with: (1) inclusion in sleep laboratory polysomnograph (PSG) testing instrumentation, (2) home-based diagnostic testing for SDB, (3) control of home-use airway therapy devices, (4) continuous remote surveillance and refinement of airway therapy, and (5) spot-check and continuous surveillance of sleep quality in the general population. The disclosed ECM also provides new measurements of physiologic stress during and following exercise. When applied during initial care of premature newborn infants, it offers improved therapeutic guidance during their transition from their limited in utero oxygen supply conditions, to the increased oxygen availability from breathing air. When applied during resuscitation of persons suffering from hypoxia and during reperfusion of ischemic tissue, such as during treatment of ischemic stroke, or ischemic heart attack, the ECM sensor can provide objective guidance regarding the safe and effective resupply of oxygen to the hypoxia-adapted tissue to help reduce or prevent microvascular occlusion and cellular injury. As a continuously worn physiologic surveillance monitor, the ECM offers the potential of early detection of sepsis. With the elderly and infirm, it offers a convenient and comfortable means of continuously assessing variations in status while awake and asleep.

A method of assessment of renal function by monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is provided that includes using a renal monitoring system comprising at least one light source, at least one light detector, at least one optical filter, and at least one controller to provide a measurement data set comprising a plurality of measurement entries, each measurement data entry comprising at least two measurements obtained at one data acquisition time from a patient before and after administration of the fluorescent agent.

A probe device provides an enhanced bioelectric and spring-loaded sensing tip with an integrated force sensor. The probe device measures the bioelectric conductance value from a patient for therapeutic and/or diagnostic purpose using the spring-loaded sensing tip. In addition, the probe device measures the force applied by the spring-loaded sensing tip against the patient using the integrated force sensor. Using feedback from the force sensor and the bioconductive data of the patient, the force applied at the spring-loaded sensing tip may be adjusted to obtain improved results.

A mobile electrocardiogram (ECG) device is described, comprising an electrode assembly comprising electrodes that sense heart-related signals when in contact with a body of a user, and produce electrical signals representing the sensed heart-related signals. The mobile ECG device further comprises a light-emitting device to facilitate an optimal placement of the electrode on the body of the user. The mobile ECG device further comprises a housing containing the electrode assembly, the converter assembly, the transmitter, and the light-emitting device. A first electrode of the electrode assembly forms a first side of the housing and comprises an opening through which the light-emitting device provides the UV light.